It should be noted that the anti-estrogenic mechanism of TBC may involve the estrogen receptor alpha (ERα) pathway, as confirmed by the lack of an effect of TBC and E2 on the inhibition of proliferation of the ERα-negative human breast cancer cell line MDA-MB-231 (Cao et al., 2018). The gene discussed is ESR1; the disease is breast carcinoma.